Published in Clin Microbiol Infect on February 22, 2008
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol (2010) 2.89
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrob Agents Chemother (2009) 2.41
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother (2013) 2.14
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrob Agents Chemother (2008) 2.13
National surveillance of fungemia in Denmark (2004 to 2009). J Clin Microbiol (2010) 2.10
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol (2012) 1.28
Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol (2011) 1.23
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. J Clin Microbiol (2009) 1.22
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007. BMC Infect Dis (2010) 1.18
Risk factors for fluconazole-resistant candidemia. Antimicrob Agents Chemother (2010) 1.16
C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Mol Immunol (2010) 1.11
Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method. Antimicrob Agents Chemother (2015) 0.99
Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system. J Biol Chem (2010) 0.96
Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis. Antimicrob Agents Chemother (2012) 0.91
Multilocus microsatellite markers for molecular typing of Candida glabrata: application to analysis of genetic relationships between bloodstream and digestive system isolates. J Clin Microbiol (2010) 0.89
Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNA. Eur J Clin Microbiol Infect Dis (2011) 0.87
Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis. Eukaryot Cell (2014) 0.82
Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole. Curr Drug Metab (2013) 0.79
Accurate and rapid identification of Candida spp. frequently associated with fungemia by using PCR and the microarray-based Prove-it Sepsis assay. J Clin Microbiol (2012) 0.79
Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. BMC Infect Dis (2015) 0.79
In Vitro Susceptibility and Trailing Growth Effect of Clinical Isolates of Candida Species to Azole Drugs. Jundishapur J Microbiol (2016) 0.75
Prospective observational multicenter study to define a diagnostic algorithm for biliary candidiasis. World J Gastroenterol (2014) 0.75
Herpes Simplex Virus (HSV) Modulation of Staphylococcus aureus and Candida albicans Initiation of HeLa 299 Cell-Associated Biofilm. Curr Microbiol (2016) 0.75
Comparison of BACTEC™ blood culture media for the detection of fungemia. Eur J Clin Microbiol Infect Dis (2016) 0.75
Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J Virol (1998) 3.98
House dust mite control measures for asthma: systematic review. Allergy (2008) 3.71
[Treatment of upper respiratory tract infections]. Ugeskr Laeger (2000) 3.46
Sites and thermodynamic quantities associated with proton and metal ion interaction with ribonucleic acid, deoxyribonucleic acid, and their constituent bases, nucleosides, and nucleotides. Chem Rev (1971) 2.30
Effects of targeting herpes simplex virus type 1 gD to the endoplasmic reticulum and trans-Golgi network. J Virol (1999) 2.10
DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J Clin Microbiol (1995) 2.04
Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand (1981) 2.03
[Guidelines on antibiotics in the Laegeforeningens Medicinfortegnelse 2000]. Ugeskr Laeger (2001) 1.93
An evaluation of the effects of a high concentration of sucrose in blood culture media. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.88
Site-directed and linker insertion mutagenesis of herpes simplex virus type 1 glycoprotein H. J Virol (1997) 1.88
Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics. Clin Microbiol Infect (2005) 1.79
Plasma membrane requirements for cell fusion induced by herpes simplex virus type 1 glycoproteins gB, gD, gH and gL. J Gen Virol (2001) 1.78
Capnocytophaga canimorsus septicemia in Denmark, 1982-1995: review of 39 cases. Clin Infect Dis (1996) 1.75
Aphasia in acute stroke. Stroke (1976) 1.67
Lautropia mirabilis gen. nov., sp. nov., a gram-negative motile coccus with unusual morphology isolated from the human mouth. Microbiology (1994) 1.66
Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study. Neurology (2010) 1.66
Infections following epidural catheterization. J Hosp Infect (1995) 1.66
Routine versus selective antifungal administration for control of fungal infections in patients with cancer. Cochrane Database Syst Rev (2002) 1.61
Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis (1996) 1.59
Voriconazole versus amphotericin B in cancer patients with neutropenia. Cochrane Database Syst Rev (2006) 1.55
Respiratory syncytial virus infection--risk factors for hospital admission: a case-control study. Acta Paediatr (2003) 1.53
Cloning and expression of treponema pallidum common antigen (Tp-4) in Escherichia coli K12. J Gen Microbiol (1987) 1.44
Ciprofloxacin as prophylaxis for urinary tract infection: prospective, randomized, cross-over, placebo controlled study in patients with spinal cord lesion. J Urol (1994) 1.43
[Long-term carrier state of methicillin resistant Staphylococcus aureus after hospitalization]. Ugeskr Laeger (1994) 1.40
The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect (2012) 1.39
Molecular characterization of VIM-producing Klebsiella pneumoniae from Scandinavia reveals genetic relatedness with international clonal complexes encoding transferable multidrug resistance. Clin Microbiol Infect (2011) 1.38
[Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation]. Ugeskr Laeger (1992) 1.38
Rupture in small abdominal aortic aneurysms. J Vasc Surg (1998) 1.38
A simple method to test if the internal mammary lymph nodes are covered by the wide tangent technique in radiotherapy for high-risk breast cancer. Clin Oncol (R Coll Radiol) (2003) 1.38
Computer simulation of immunochemical interactions. Immunology (1975) 1.36
Direct identification and susceptibility testing of enteric bacilli from positive blood cultures using VITEK (GNI+/GNS-GA). Clin Microbiol Infect (2002) 1.35
The data quality of haematological malignancy ICD-10 diagnoses in a population-based hospital discharge registry. Eur J Cancer Prev (2005) 1.34
Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme. Clin Microbiol Infect (2013) 1.34
Double-blind study of the effects of dexamethasone on acute stroke. Neurology (1972) 1.33
Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis. BMJ (1998) 1.33
Cross-reactive antigen recognition by an encephalitogenic T cell receptor. Implications for T cell biology and autoimmunity. J Immunol (1992) 1.30
[Treatment of upper respiratory tract infections?]. Ugeskr Laeger (2000) 1.29
In vitro antimicrobial susceptibility of Aerococcus urinae to 14 antibiotics, and time-kill curves for penicillin, gentamicin and vancomycin. J Antimicrob Chemother (2001) 1.29
A nationwide study of the incidence and 30-day mortality rate of pyogenic liver abscess in Denmark, 1977-2002. Aliment Pharmacol Ther (2005) 1.28
House dust mite control measures for asthma. Cochrane Database Syst Rev (2004) 1.28
Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin Microbiol Infect (2010) 1.27
Fungemia with Saccharomycetaceae. Report of four cases and review of the literature. Scand J Infect Dis (1990) 1.27
Direct identification of major blood culture pathogens, including Pseudomonas aeruginosa and Escherichia coli, by a panel of fluorescence in situ hybridization assays using peptide nucleic acid probes. J Clin Microbiol (2005) 1.27
The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol (1987) 1.26
Genetic heterogeneity of Flavobacterium meningosepticum demonstrated by DNA-DNA hybridization. Acta Pathol Microbiol Immunol Scand B (1987) 1.26
Source of infection and other factors associated with case fatality in community-acquired bacteremia--a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect (2003) 1.25
Invasive listeriosis in Denmark 1994-2003: a review of 299 cases with special emphasis on risk factors for mortality. Clin Microbiol Infect (2005) 1.25
Neurological complications of addiction to heroin. Bull N Y Acad Med (1973) 1.24
Thermodynamic pK, delta H-o, delta S-o, and delta Cp-o values for proton dissociation from several purines and their nucleosides in aqueous solution. Biochemistry (1970) 1.24
The community health worker. A resource for improved health care delivery. Am J Public Health (1974) 1.24
Pyogenic hepatic abscess. A 10-year population-based retrospective study. APMIS (1998) 1.22
Ion binding by synthetic macrocyclic compounds. Science (1971) 1.21
Can hospital discharge diagnosis be used for surveillance of bacteremia? A data quality study of a Danish hospital discharge registry. Infect Control Hosp Epidemiol (1998) 1.20
Increased incidence of Mycoplasma pneumoniae infections detected by laboratory-based surveillance in Denmark in 2010. Euro Surveill (2010) 1.20
Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits. Antimicrob Agents Chemother (1998) 1.19
Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice. APMIS (1997) 1.19
Nontraumatic plexitis and heroin addiction. JAMA (1973) 1.19
Bactec 9240 blood culture system: to preincubate at 35 degrees C or not? Clin Microbiol Infect (2004) 1.18
House dust mite control measures for asthma. Cochrane Database Syst Rev (2008) 1.17
Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand J Infect Dis (1994) 1.16
Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol (1990) 1.16
Ribotyping for differentiating Flavobacterium meningosepticum isolates from clinical and environmental sources. J Clin Microbiol (1994) 1.15
Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis (2000) 1.15
Social science perspectives on schistosomiasis control in Africa: past trends and future directions. Parasitology (2009) 1.15
Branhamella catarrhalis: significance in pulmonary infections and bacteriological features. Acta Pathol Microbiol Immunol Scand B (1986) 1.14
Risk and patterns of bacteraemia after splenectomy: a population-based study. Scand J Infect Dis (2000) 1.14
Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol (2001) 1.13
The risk and prognosis of cancer after hospitalisation for herpes zoster: a population-based follow-up study. Br J Cancer (2004) 1.13
Phenotypic characterization of Flavobacterium meningosepticum strains identified by DNA-DNA hybridization. Acta Pathol Microbiol Immunol Scand B (1987) 1.13
Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011. Euro Surveill (2012) 1.12
Clinical significance and taxonomy of Actinobacillus hominis. J Clin Microbiol (2001) 1.12
Secular trends in incidence and mortality of bacteraemia in a Danish county 1981-1994. APMIS (1999) 1.12
Fatal septicaemia with Selenomonas sputigena and Acinetobacter calcoaceticus. A case report. APMIS (1991) 1.10
Long-term survival and nutritional data in patients with cystic fibrosis treated in a Danish centre. Thorax (1996) 1.08
Attachment of staphylococci to silicone catheters in vitro. APMIS (1990) 1.08
Outcome of pre-hospital antibiotic treatment of meningococcal disease. J Clin Epidemiol (1998) 1.08
Penicillin pharmacodynamics in four experimental pneumococcal infection models. Antimicrob Agents Chemother (2001) 1.07
Phylogeny of the genus Haemophilus as determined by comparison of partial infB sequences. Microbiology (2001) 1.07
Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study. Clin Microbiol Infect (2013) 1.07
An investigation of three commercial methods for rapid identification of non-enteric gram-negative rods. Application on Pseudomonas paucimobilis and some other Pseudomonas species. Acta Pathol Microbiol Immunol Scand B (1986) 1.07
Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model. Antimicrob Agents Chemother (1997) 1.06
Outbreak of infection with Achromobacter xylosoxidans from contaminated intravascular pressure transducers. J Hosp Infect (1988) 1.06
Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect Immun (1991) 1.06
Hepatitis A vaccine. A new convenient single-dose schedule with booster when long-term immunization is warranted. Vaccine (1994) 1.06
Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. Antimicrob Agents Chemother (2000) 1.05
Actinomyces species: A danish survey on human infections and microbiological characteristics. Open Microbiol J (2009) 1.05
Frequency of the delta F508 mutation on cystic fibrosis chromosomes in Denmark. Hum Genet (1990) 1.05
Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS (1997) 1.05
Long-lasting improvement in general practitioners' prescribing of antibiotics by means of medical audit. Scand J Prim Health Care (1999) 1.04